What is Zacks Research’s Estimate for MMSI FY2025 Earnings?

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Equities researchers at Zacks Research cut their FY2025 earnings estimates for shares of Merit Medical Systems in a research report issued on Tuesday, March 18th. Zacks Research analyst I. Bandyopadhyay now expects that the medical instruments supplier will earn $3.67 per share for the year, down from their prior estimate of $3.70. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.37 per share.

MMSI has been the topic of several other reports. Piper Sandler reiterated an “overweight” rating and set a $116.00 target price (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Needham & Company LLC dropped their price objective on shares of Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 26th. Barrington Research lowered their price target on shares of Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating for the company in a report on Wednesday, February 26th. Finally, Raymond James boosted their price objective on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Tuesday, December 31st. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $110.78.

Merit Medical Systems Trading Up 0.4 %

Shares of MMSI opened at $101.68 on Friday. Merit Medical Systems has a 12 month low of $70.70 and a 12 month high of $111.45. The stock’s 50-day moving average is $103.93 and its two-hundred day moving average is $100.75. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. The stock has a market cap of $5.98 billion, a PE ratio of 49.84, a P/E/G ratio of 2.34 and a beta of 0.91.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. NewSquare Capital LLC bought a new position in Merit Medical Systems in the fourth quarter worth about $32,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Merit Medical Systems in the 4th quarter worth approximately $52,000. Federated Hermes Inc. lifted its holdings in shares of Merit Medical Systems by 139.1% in the 4th quarter. Federated Hermes Inc. now owns 655 shares of the medical instruments supplier’s stock worth $63,000 after purchasing an additional 381 shares during the last quarter. Group One Trading LLC acquired a new position in Merit Medical Systems during the 4th quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd bought a new position in Merit Medical Systems during the 3rd quarter worth $120,000. 99.66% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Fred P. Lampropoulos sold 31,320 shares of Merit Medical Systems stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $103.86, for a total value of $3,252,895.20. Following the completion of the transaction, the chief executive officer now owns 1,086,028 shares in the company, valued at approximately $112,794,868.08. This trade represents a 2.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Raul Jr. Parra sold 12,451 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $98.81, for a total value of $1,230,283.31. Following the completion of the sale, the chief financial officer now owns 24,201 shares of the company’s stock, valued at $2,391,300.81. This trade represents a 33.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 109,132 shares of company stock valued at $11,139,521 in the last ninety days. Corporate insiders own 3.70% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.